Rationale for the use of mitoxantrone in the older patient: cardiac toxicity

Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response.

Scientific reports·2024

Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.

Scientific reports·2017

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Annals of oncology : official journal of the European Society for Medical Oncology·2014

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2012

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor.

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Of mice and men: divergent risks of teriparatide-induced osteosarcoma.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2009

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Seminars in oncology·2026

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Seminars in oncology·2026

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Seminars in oncology·2026

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation.

Frontiers in oncology·2026

Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.

Frontiers in medicine·2026

Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report.

Frontiers in immunology·2026

Lysosome-Bursting Calcium Carbonate Nanoparticles Amplify Immunogenic Cell Death via Synergistic Phototherapy and Calcium Overload for Immune Checkpoint Blockade.

Research (Washington, D.C.)·2026

Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.

Frontiers in medical technology·2026

Stable disease after multimodal treatment of SMARCA4-deficient undifferentiated tumor concurrently involving the stomach and mediastinum: a case report.

Frontiers in oncology·2026

Related Experiment Videos

Rationale for the use of mitoxantrone in the older patient: cardiac toxicity

Related Concept Videos

Perfusion-weighted imaging with dynamic contrast enhancement (PWI/DCE) morphologic, qualitative, semiquantitative, and radiomics features predicting undifferentiated pleomorphic sarcoma (UPS) treatment response.

Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard.

Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas.

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor.

Of mice and men: divergent risks of teriparatide-induced osteosarcoma.

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Peri-interventional neutrophil extracellular traps and immune surveillance in hepatocellular carcinoma: mechanisms, biomarkers, and recurrence after liver resection or thermal ablation.

Enhancing intravesical bladder cancer therapy: from mucoadhesive to targeted drug delivery strategies.

Gefitinib-based therapy in refractory hepatocellular carcinoma with EGFR overexpression: a spatial profiling-guided case report.

Lysosome-Bursting Calcium Carbonate Nanoparticles Amplify Immunogenic Cell Death via Synergistic Phototherapy and Calcium Overload for Immune Checkpoint Blockade.

Bio-based nanophotothermal systems as smart drug delivery platforms for multimodal synergistic cancer therapy-a review.

Stable disease after multimodal treatment of SMARCA4-deficient undifferentiated tumor concurrently involving the stomach and mediastinum: a case report.

Related Experiment Videos

Rationale for the use of mitoxantrone in the older patient: cardiac toxicity

Related Concept Videos

Related Articles